Sulaco, not to be the continual pessimist that I have been as of late but your request has two problems with it. First off we have a lack of data to review anything despite being told we will hear more details in future conferences. The second is the source of your quote. Steve King has said many things and very little have come to fruition. He needs to be accountable for what he says and stop leading investors on.
There is 0 data to back up the botched trial. Liver was meh, pancreatic a bust, first line a bust, breast tiny study. Just what clinical data are you talking about. But happy to get a fill at $1.28 today.
News 
Market Data 
Discover 
